Tripeptide tyroserleutide enhances the antitumor effects of macrophages and stimulates macrophage secretion of IL-1β, TNF-α, and NO in vitro

Cancer Immunology, Immunotherapy

Volumn 55, Issue 1, 2006, Pages 56-60

  Zhi, Yao ^a   Shuang, Qiu ^a   Li, Wang ^a   Rong, Lu ^a,b   Chun Lei, Zhou ^a   Peng Peng, Zhao ^a   Hui Qiang, Li ^a   Wen Yuan, Gao ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Shenzhen Kangzhe Pharmaceutical Co Ltd   (China)

Author keywords

Human hepatocarcinoma cell BEL 7402; IL 1 ; Macrophage; NO; TNF ; Tyroserleutide

Indexed keywords

ANTINEOPLASTIC AGENT; INTERLEUKIN 1BETA; NITRIC OXIDE; TRIPEPTIDE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; TYROSERLEUTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHARMACOLOGY; IN VITRO STUDY; MACROPHAGE ACTIVATION; MONOCYTE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; TARGET CELL DESTRUCTION; TUMOR IMMUNITY;

ANIMALS; CARCINOMA; FEMALE; HUMANS; INTERLEUKIN-1; LIVER NEOPLASMS; MACROPHAGES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; NITRIC OXIDE; OLIGOPEPTIDES; TRANSPLANTATION, HETEROLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 28944441766     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-005-0024-7     Document Type: Article

References (24)

1. Adelman DC, Erickson KL, Gershwin ME (1983) Macrophage-mediated inhibition of melanoma cell growth in nude mice. Exp Cell Biol 51:165-171
2. Bogdan C, Rollinghoff M, Diefenbach A (2000) The role of nitric oxide in innate immunity. Immunol Rev 173:17-26
3. Bump NJ, Lee J, Wleklik M, Reichler J, Najjar VA (1986) Isolation and subunit composition of tuftsin receptor. Proc Natl Acad Sci USA 83:7187-7191
4. Chen RM, Zhu DZh, Ye XZh (1975) The establishment and character of human hepacarcimoma cell line(BEL-7402)in vitro. Commun Sci 20:434-436
5. Chen ZhSh, Sun MJ, Liu ZhN (1992) The research of human lymphocyte and murine macrophage by MTT. J Shanghai Immunol 12:269
6. Ding W, Zhang J, Yao Z, Lu R, Wu D, Li G, Shen Z, Sun Y, Lin G, Wang C, Zhao M, Peng S (2004) The synthesis, distribution, and anti-hepatic cancer activity of YSL. Bioorg Med Chem 15:4989-4994
7. Dwyer JM (1996) Transfer factor in the age of molecular biology. Biotherapy 9:7-11
8. Hibbs JB Jr, Taintor RR, Vavrin Z (1987) Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 4787:473-476
9. Hill JR, Corbett JA, Kwon G, Marshall CA, McDaniel ML (1996) Nitric oxide regulates interleukin 1 bioactivity released from murine macrophages. J Biol Chem 271:22672-22678
10. Jiao H, Shen W, Ohe Y, Miura K, Tamura T, Saijo N (1992) A new 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay for testing macrophage cytotoxicity to L1210 and its drug-resistant cell lines in vitro. Cancer Immunol Immunother 35:412-416
11. Li Y, Tang ZY, Wang L, Yao Zh, Lu R, Xue Q, Gao DM, Chen J (2004) The inhibitory of tripeptide CMS024 on the metastasis of human hepatocarcinoma in nude mice. J Chin Med 84:675-679
12. Muhlradt PF, Frisch M (1994) Purification and partial biochemical characterization of a Mycoplasma fermentans-derived substance that activates macrophages to release nitric oxide, tumor necrosis factor, and interleukin-6. Infect Immun 62:3801-3807
13. Nishikawa M, Sato EF, Kuroki T, Utsumi K, Inoue M (1998) Macrophage-derived nitric oxide induces apoptosis of rat hepatoma cells in vivo. Hepatology 28:1474-1480
14. Peter Berressem (1991) Application of glycopeptide fractions in the treatment of tumor patients suffering from immunodeficiency. Therapeutikon 5:264-270
15. Sarlo KT, Mortensen RF (1985) Enhanced interleukin 1 (IL-1) production mediated by mouse serum amyloid P component. Cell Immunol 93:398-405
16. Thoeni G, Werner ER, Werner-Felmayer G (2004) Tetrahydropteridines suppress gene expression and induce apoptosis of activated RAW264.7 cells via formation of hydrogen peroxide. Free Radic Biol Med 37:375-385
17. Wang C, Ding W, Zhao M, Lin G, Peng S (2003) Studies on the large scale synthesis and anti-tumor activity of YSL. Prep Biochem Biotechnol 33:189-195
18. Watanobe H, Hayakawa Y (2003) Hypothalamic interleukin-1 beta and tumor necrosis factor-alpha, but not interleukin-6, mediate the endotoxin-induced suppression of the reproductive axis in rats. Endocrinology 144:4868-4875
19. Watanabe N, Miura S, Zeki S, Ishii H (2001) Hepatocellular oxidative DNA injury induced by macrophage-derived nitric oxide. Free Radic Biol Med 30:1019-1028
20. Whitworth PW, Pak CC, Esgro J, Kleinerman ES, Fidler IJ (1990) Macrophages and cancer. Cancer Metastasis Rev 8:319-351
21. Xiang LB (1994) The research of macrophage on molecular ecology. J Immunol 10:1
22. Xu ChL, Ye TX, Lu DY (1998) Modern medical immunology, 1st edn. Shanghai medical university publishing house, Shanghai, p 146
23. Xu ShY, Bian RL, Chen X (2002) The methods of pharmacological experiments,3rd edn. Peoples Health Publishing House, Beijing, pp 1785-1786
24. Zhong YD, Shan L, You BZh (1989) Effects of pretreatment with protein kinase C activators on macrophages activation for tumor cytotoxicity secretion of tumor necrosis factor and its mRNA expression. Immunobiology 179:382